APA (7th ed.) Citation

Skvara, H., Dawid, M., Kleyn, E., Wolff, B., Meingassner, J. G., Knight, H., . . . Jung, T. (2008). The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. The Journal of clinical investigation, 118(9), 3151-3159. https://doi.org/10.1172/JCI35636

Chicago Style (17th ed.) Citation

Skvara, Hans, et al. "The PKC Inhibitor AEB071 May Be a Therapeutic Option for Psoriasis." The Journal of Clinical Investigation 118, no. 9 (2008): 3151-3159. https://doi.org/10.1172/JCI35636.

MLA (9th ed.) Citation

Skvara, Hans, et al. "The PKC Inhibitor AEB071 May Be a Therapeutic Option for Psoriasis." The Journal of Clinical Investigation, vol. 118, no. 9, 2008, pp. 3151-3159, https://doi.org/10.1172/JCI35636.